TY - JOUR
T1 - Microbiological Methods Used in the Enterics for Global Health Shigella Surveillance Study
AU - Horne, Bri'Anna
AU - Badji, Henry
AU - Bhuiyan, Md Taufiqur Rahman
AU - Cachique, Lucero Romaina
AU - Cornick, Jennifer
AU - Hotwani, Aneeta
AU - Juma, Jane
AU - Ochieng, John Benjamin
AU - Abdou, Mahamadou
AU - Apondi, Evans
AU - Atlas, Hannah E.
AU - Awuor, Alex O.
AU - Baker, Kate S.
AU - Ceesay, Bubacarr E.
AU - Charles, Mary
AU - Cunliffe, Nigel A.
AU - Feutz, Erika
AU - Galagan, Sean R.
AU - Guindo, Ibrehima
AU - Jahangir Hossain, M.
AU - Iqbal, Junaid
AU - Jallow, Fatima
AU - Keita, Noumou Yakhouba
AU - Khanam, Farhana
AU - Kotloff, Karen L.
AU - Maiden, Victor
AU - Villanueva, Katia Manzanares
AU - Mito, Oscar
AU - Mosharraf, Md Parvej
AU - Nkeze, Joseph
AU - Ikumapayi, Usman N.
AU - Olortegui, Maribel Paredes
AU - Pavlinac, Patricia B.
AU - Vasquez, Tackeshy Pinedo
AU - Qadri, Firdausi
AU - Qamar, Farah Naz
AU - Qureshi, Sonia
AU - Rahman, Nazia
AU - Sangare, Aminata
AU - Sen, Sunil
AU - Yori, Pablo Peñataro
AU - Yousafzai, Mohammad Tahir
AU - Ahmed, Dilruba
AU - Jere, Khuzwayo C.
AU - Kosek, Margaret N.
AU - Omore, Richard
AU - Permala-Booth, Jasnehta
AU - Secka, Ousman
AU - Tennant, Sharon M.
N1 - Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Background. Shigella is a major cause of diarrhea in young children worldwide. Multiple vaccines targeting Shigella are in development, and phase 3 clinical trials are imminent to determine efficacy against shigellosis. Methods. The Enterics for Global Health (EFGH) Shigella surveillance study is designed to determine the incidence of medically attended shigellosis in 6- to 35-month-old children in 7 resource-limited settings. Here, we describe the microbiological methods used to isolate and identify Shigella. We developed a standardized laboratory protocol for isolation and identification of Shigella by culture. This protocol was implemented across all 7 sites, ensuring consistency and comparability of results. Secondary objectives of the study are to determine the antibiotic resistance profiles of Shigella, compare isolation of Shigella from rectal swabs versus whole stool, and compare isolation of Shigella following transport of rectal swabs in Cary-Blair versus a modified buffered glycerol saline transport medium. Conclusions. Data generated from EFGH using culture methods described herein can potentially be used for microbiological endpoints in future phase 3 clinical trials to evaluate vaccines against shigellosis and for other clinical and public health studies focused on these organisms.
AB - Background. Shigella is a major cause of diarrhea in young children worldwide. Multiple vaccines targeting Shigella are in development, and phase 3 clinical trials are imminent to determine efficacy against shigellosis. Methods. The Enterics for Global Health (EFGH) Shigella surveillance study is designed to determine the incidence of medically attended shigellosis in 6- to 35-month-old children in 7 resource-limited settings. Here, we describe the microbiological methods used to isolate and identify Shigella. We developed a standardized laboratory protocol for isolation and identification of Shigella by culture. This protocol was implemented across all 7 sites, ensuring consistency and comparability of results. Secondary objectives of the study are to determine the antibiotic resistance profiles of Shigella, compare isolation of Shigella from rectal swabs versus whole stool, and compare isolation of Shigella following transport of rectal swabs in Cary-Blair versus a modified buffered glycerol saline transport medium. Conclusions. Data generated from EFGH using culture methods described herein can potentially be used for microbiological endpoints in future phase 3 clinical trials to evaluate vaccines against shigellosis and for other clinical and public health studies focused on these organisms.
KW - children
KW - diarrhea
KW - dysentery
KW - microbiology
KW - Shigella
UR - http://www.scopus.com/inward/record.url?scp=85188795439&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofad576
DO - 10.1093/ofid/ofad576
M3 - Article
AN - SCOPUS:85188795439
SN - 2328-8957
VL - 11
SP - S25-S33
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - Supplement_1
ER -